Megan D. Bailey
Known title: EVP, Chief Strategy OfficerCIK: 0001975682
Associated companies
Transaction History
| LH | ▲ Buy | Grant | 1,184 | $0 | 3/26/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 481 | $129K | 3/26/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 403 | — | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 138 | $40K | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 85 | $23K | 2/9/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 23 | $6K | 2/9/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 222 | — | 2/7/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 67 | — | 2/7/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 72 | $20K | 2/6/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 180 | — | 2/6/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 179 | $46K | 11/3/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 370 | — | 11/1/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 1,546 | $360K | 4/1/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 68 | $16K | 4/1/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 204 | — | 4/1/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 4,083 | — | 4/1/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 22 | $5K | 2/7/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 85 | $21K | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 67 | — | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 224 | — | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 180 | — | 2/6/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 70 | $17K | 2/6/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 69 | $15K | 4/1/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 205 | — | 4/1/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 26 | $6K | 2/7/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 224 | — | 2/7/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 87 | $19K | 2/7/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 67 | — | 2/7/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M
Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.